Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 2
1964 2
1967 1
1970 1
1971 2
1972 3
1973 3
1974 3
1975 4
1976 2
1977 1
1978 10
1979 3
1980 11
1981 7
1982 7
1983 7
1984 10
1985 14
1986 12
1987 8
1988 14
1989 7
1990 10
1991 5
1992 9
1993 9
1994 10
1995 11
1996 7
1997 9
1998 4
1999 6
2000 4
2001 5
2002 4
2003 1
2004 5
2005 4
2006 4
2008 4
2009 1
2010 2
2011 2
2012 2
2013 2
2015 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

253 results
Results by year
Filters applied: . Clear all
Page 1
Infliximab for induction and maintenance therapy for ulcerative colitis.
Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF. Rutgeerts P, et al. Among authors: rachmilewitz d. N Engl J Med. 2005 Dec 8;353(23):2462-76. doi: 10.1056/NEJMoa050516. N Engl J Med. 2005. PMID: 16339095 Free article. Clinical Trial.
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P; ACCENT I Study Group. Hanauer SB, et al. Among authors: rachmilewitz d. Lancet. 2002 May 4;359(9317):1541-9. doi: 10.1016/S0140-6736(02)08512-4. Lancet. 2002. PMID: 12047962 Clinical Trial.
Infliximab, azathioprine, or combination therapy for Crohn's disease.
Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens G, Diamond RH, Broussard DL, Tang KL, van der Woude CJ, Rutgeerts P; SONIC Study Group. Colombel JF, et al. Among authors: rachmilewitz d. N Engl J Med. 2010 Apr 15;362(15):1383-95. doi: 10.1056/NEJMoa0904492. N Engl J Med. 2010. PMID: 20393175 Free article. Clinical Trial.
Infliximab maintenance therapy for fistulizing Crohn's disease.
Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Sands BE, et al. Among authors: rachmilewitz d. N Engl J Med. 2004 Feb 26;350(9):876-85. doi: 10.1056/NEJMoa030815. N Engl J Med. 2004. PMID: 14985485 Free article. Clinical Trial.
Diffuse intramural esophageal pseudodiverticulosis.
Eliakim R, Libson E, Rachmilewitz D. Eliakim R, et al. Among authors: rachmilewitz d. J Natl Med Assoc. 1989 Jan;81(1):93, 96-8. J Natl Med Assoc. 1989. PMID: 2498526 Free PMC article. Review.
Sulfasalazine hepatotoxicity.
Fich A, Schwartz J, Braverman D, Zifroni A, Rachmilewitz D. Fich A, et al. Among authors: rachmilewitz d. Am J Gastroenterol. 1984 May;79(5):401-2. Am J Gastroenterol. 1984. PMID: 6144268
Dermatomyositis associated with Crohn's disease.
Leibowitz G, Eliakim R, Amir G, Rachmilewitz D. Leibowitz G, et al. Among authors: rachmilewitz d. J Clin Gastroenterol. 1994 Jan;18(1):48-52. doi: 10.1097/00004836-199401000-00012. J Clin Gastroenterol. 1994. PMID: 8113586 Review.
[Probiotics--myth or benefit?].
Shibolet O, Eliakim R, Rachmilewitz D. Shibolet O, et al. Among authors: rachmilewitz d. Harefuah. 1999 Dec 15;137(12):620-3. Harefuah. 1999. PMID: 10959390 Review. Hebrew. No abstract available.
253 results